Trial intelligence / Profile preview

Adductor canal block vs placebo for early postoperative function after total knee arthroplasty

2014-002245-21Phase 4Completed

Sponsor
Ulrik Grevstad
Start
Jun 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in postoperative pain comparing Ropivacaine adductor canal block with Placebo adductor canal block (2 arms). Primary endpoint: Quadriceps muscle strength (MVIC) at 1 hour post block. Started Jun 2014; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2014-002245-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002245-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call